NCT03619395

Unknown

Risc Optimisation- Acute cor5onary Syndrome

Parc de Salut Mar Source

Compare

Other study identifiers

Sponsor study identifier

ParcSM

Study Type

observational

Estimated enrollment

150

Locations

1 country

Sites

1

Timeline

Study Start

September 1, 2018

Actual (reported)

Primary Completion

July 1, 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 1, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

This study evaluates the percentage of patients that reach the objective levels of LDL cholesterol, glycosylated hemoglobin and blood pressure recommended by clinical guidelines after an acute coronary syndrome, following strategies of pharmacological optimization based on algorithms. The investigators hypothesize that the use of algorithms designed and protocolized within a cardiac rehabilitation program after an ACS to optimize pharmacological treatment is effective and safe to improve the control of risk factors in patients with high cardiovascular risk.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 150 participants
Study completion date: July 1, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
June 26, 2018
Actual (reported)
First Posted
August 7, 2018
Actual (reported)
Study Start
September 1, 2018
Actual (reported)
Primary Completion
July 1, 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 1, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: September 6, 2019
Status Verified: September 2019
Last Update Submitted: September 4, 2019

Conditions

Acute Coronary Syndrome Ischemic Heart Disease

Keywords

Cardiovascular Secondary preventionCardiovascular risk factors control

Outcome Measures

Primary Outcomes (1)

Percentage of patients that reach the objective levels of LDL cholesterol and glycosylated hemoglobin recommended in the clinical guidelines
LDL cholesterol and glycosylated hemoglobin levels
12 months

Secondary Outcomes (1)

Percentage of patients that reach the objective levels of LDL cholesterol and glycosylated the long term.
5 years

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Patients with high cardiovascular risk

You may qualify if:

patients hospitalized with a diagnosis of acute coronary syndrome who have signed informed consent

You may not qualify if:

Sponsors & Collaborators

Parc de Salut Mar
Otherlead

Study Sites (1)

Sonia Ruiz Bustillo

Barcelona, 08003, Spain

RECRUITING

Sonia Ruiz Bustillo, MDCONTACT0034932483118 ext. 3118 sruiz@parcdesalutmar.cat

Consol Ivern DiazCONTACT0034932483118 ext. 3118 civern@parcdesalutmar.cat

MeSH Terms

Conditions

Acute Coronary SyndromeMyocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular Diseases

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Target Duration: 5 Years
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: MD

Study Record Dates

First Submitted

June 26, 2018

First Posted

August 7, 2018

Study Start

September 1, 2018

Actual (reported)

Primary Completion

July 1, 2020

Estimated (date passed)

NCT05756452

Linking Cardiac Autonomic Dysfunction and InfLammation in Patients With Acute Coronary Syndromes

Not ApplicableUnknown

NCT00089895

EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)

Phase 3Completed

NCT01272986

Trial of Screening for ALOA-IgG AtheroAbzyme Test

Phase 3Completed

NCT00404781

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

Phase 4Completed

NCT00405717

Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel

Phase 4Completed

NCT05787886

Rotational Atherectomy: Long-term Results From a Single Center Experience

Unknown

patients with disability or refusal to sign informed consent or who have comorbidities with a life expectancy of less than 1 year

Contact the study team to confirm eligibility.

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 1, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

September 6, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing: Will share
Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR
Time Frame: Data will be available within 12 months of study completion
Access Criteria: Requestors will be required to sign a Data Access Agreement

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03619395
Data provider: ClinicalTrials.gov
Source updated: 2019-09-06
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:39:27 UTC

Locations

ES(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Data Sharing

Source record

Locations